One protein mitigates Huntington’s disease while another one exacerbates it by regulating the huntingtin protein’s movement in neurons.

Weeks after an injection of stem cells delivered to the brain, 80% of patients had improved CSF biomarkers with no adverse effects.

The transition from preclinical development to clinical trials is a critical, with approximately 89% of drugs failing. Nearly half of these failures stem from unexpected and unmanageable human ...

Chromatography has long been a bioprocess cornerstone but many platforms today are struggling to keep up with scale, speed, ...

Recursion said it earned its latest milestone payout by identifying differentiated, oral small molecule leads against a target the company described as a high interest immune cell target in immunology ...